ATE496943T1 - Biotinylierte mhc-komplexe und ihre verwendungen - Google Patents
Biotinylierte mhc-komplexe und ihre verwendungenInfo
- Publication number
- ATE496943T1 ATE496943T1 AT07101561T AT07101561T ATE496943T1 AT E496943 T1 ATE496943 T1 AT E496943T1 AT 07101561 T AT07101561 T AT 07101561T AT 07101561 T AT07101561 T AT 07101561T AT E496943 T1 ATE496943 T1 AT E496943T1
- Authority
- AT
- Austria
- Prior art keywords
- mhc complexes
- biotinylated mhc
- biotinylated
- multimerising
- immobilizing
- Prior art date
Links
- 230000006287 biotinylation Effects 0.000 abstract 1
- 238000007413 biotinylation Methods 0.000 abstract 1
- 230000004927 fusion Effects 0.000 abstract 1
- 230000003100 immobilizing effect Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56977—HLA or MHC typing
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/90—Fusion polypeptide containing a motif for post-translational modification
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/70539—MHC-molecules, e.g. HLA-molecules
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2440/00—Post-translational modifications [PTMs] in chemical analysis of biological material
- G01N2440/32—Post-translational modifications [PTMs] in chemical analysis of biological material biotinylation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
- G01N2800/245—Transplantation related diseases, e.g. graft versus host disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0614735A GB2442048B (en) | 2006-07-25 | 2006-07-25 | Biotinylated MHC complexes and their uses |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE496943T1 true ATE496943T1 (de) | 2011-02-15 |
Family
ID=37006102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07101561T ATE496943T1 (de) | 2006-07-25 | 2007-02-01 | Biotinylierte mhc-komplexe und ihre verwendungen |
Country Status (6)
Country | Link |
---|---|
US (2) | US20080038282A1 (de) |
EP (1) | EP1882700B1 (de) |
AT (1) | ATE496943T1 (de) |
DE (1) | DE602007012176D1 (de) |
DK (1) | DK1882700T3 (de) |
GB (1) | GB2442048B (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3878922B2 (ja) * | 2003-04-24 | 2007-02-07 | 独立行政法人科学技術振興機構 | 脂質セカンドメッセンジャー検出・定量用プローブとそれを用いた脂質セカンドメッセンジャーの検出および定量方法 |
WO2011103172A1 (en) * | 2010-02-17 | 2011-08-25 | One Lambda, Inc. | Compositions and methods for the detection of antibodies to native human leukocyte antigen |
WO2012149562A2 (en) * | 2011-04-29 | 2012-11-01 | The Board Of Regents Of The University Of Oklahoma | Selective anti-hla antibody removal device and methods of production and use thereof |
EP2817625A2 (de) | 2012-02-23 | 2014-12-31 | Stage Cell Therapeutics GmbH | Chromatografische isolierung von zellen und anderen komplexen biologischen materialien |
MA45489A (fr) | 2015-10-22 | 2018-08-29 | Juno Therapeutics Gmbh | Procédés de culture de cellules, kits et appareil associés |
US10294454B2 (en) | 2016-08-24 | 2019-05-21 | General Electric Company | Methods and kits for cell activation |
CN116693695A (zh) | 2017-02-12 | 2023-09-05 | 百欧恩泰美国公司 | 基于hla的方法和组合物及其用途 |
TW201842335A (zh) | 2017-04-27 | 2018-12-01 | 德商朱諾醫療公司 | 寡聚粒子試劑及其使用方法 |
WO2020132586A1 (en) | 2018-12-21 | 2020-06-25 | Neon Therapeutics, Inc. | Method and systems for prediction of hla class ii-specific epitopes and characterization of cd4+ t cells |
KR20210113655A (ko) | 2019-01-10 | 2021-09-16 | 얀센 바이오테크 인코포레이티드 | 전립선 신생항원 및 이의 용도 |
TW202144388A (zh) | 2020-02-14 | 2021-12-01 | 美商健生生物科技公司 | 在卵巢癌中表現之新抗原及其用途 |
TW202144389A (zh) | 2020-02-14 | 2021-12-01 | 美商健生生物科技公司 | 在多發性骨髓瘤中表現之新抗原及其用途 |
CN112125959B (zh) * | 2020-10-10 | 2022-07-29 | 中山大学肿瘤防治中心 | 一种抑制eb病毒的肽和编码该肽的dna及其应用 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2003A (en) * | 1841-03-12 | Improvement in horizontal windivhlls | ||
DE3825615A1 (de) * | 1988-07-28 | 1990-02-01 | Behringwerke Ag | Antigenkonstrukte von "major histocompatibility complex" klasse i antigenen mit spezifischen traegermolekuelen, ihre herstellung und verwendung |
US5252466A (en) * | 1989-05-19 | 1993-10-12 | Biotechnology Research And Development Corporation | Fusion proteins having a site for in vivo post-translation modification and methods of making and purifying them |
DE4237113B4 (de) * | 1992-11-03 | 2006-10-12 | "Iba Gmbh" | Peptide und deren Fusionsproteine, Expressionsvektor und Verfahren zur Herstellung eines Fusionsproteins |
US5861156A (en) * | 1993-01-08 | 1999-01-19 | Creative Biomolecules | Methods of delivering agents to target cells |
CN1112933A (zh) * | 1994-01-20 | 1995-12-06 | 伯伦格·曼海姆有限公司 | 抗原特异性活化t淋巴细胞,其检测和用途 |
US5670132A (en) * | 1994-09-20 | 1997-09-23 | Immunomedics, Inc. | Modified radioantibody fragments for reduced renal uptake |
US5635363A (en) | 1995-02-28 | 1997-06-03 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for the detection, quantitation and purification of antigen-specific T cells |
US20020151707A1 (en) * | 1995-06-07 | 2002-10-17 | Corixa Corp. | Immune mediators and related methods |
JP2000504934A (ja) * | 1995-12-22 | 2000-04-25 | バクスター バイオテク テクノロジー エス.アー.アール.エル. | 結合ドメインを含むグロビン |
WO1998005684A2 (en) * | 1996-08-05 | 1998-02-12 | President And Fellows Of Havard College | Mhc binding peptide oligomers and methods of use |
US20050003431A1 (en) * | 1996-08-16 | 2005-01-06 | Wucherpfennig Kai W. | Monovalent, multivalent, and multimeric MHC binding domain fusion proteins and conjugates, and uses therefor |
DE19641876B4 (de) * | 1996-10-10 | 2011-09-29 | Iba Gmbh | Streptavidinmuteine |
US6248564B1 (en) * | 1997-08-29 | 2001-06-19 | Harvard University | Mutant MHC class I molecules |
US8609436B2 (en) * | 2000-03-17 | 2013-12-17 | Guy's & St Thomas' Hospital NHS Trust (“GST”) | Method |
AU2001255326B2 (en) * | 2000-04-12 | 2005-12-15 | University Of Rochester | Targeted vaccine delivery systems |
US20020082411A1 (en) * | 2001-01-23 | 2002-06-27 | Darrick Carter | Immune mediators and related methods |
DE10117858A1 (de) * | 2001-04-10 | 2002-10-24 | Gsf Forschungszentrum Umwelt | MHC-Tetramere |
US6811785B2 (en) * | 2001-05-07 | 2004-11-02 | Mount Sinai School Of Medicine Of New York University | Multivalent MHC class II—peptide chimeras |
US6902921B2 (en) * | 2001-10-30 | 2005-06-07 | 454 Corporation | Sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
GB0202018D0 (en) * | 2002-01-29 | 2002-03-13 | Sense Proteomic Ltd | Tag and method |
US20040132133A1 (en) * | 2002-07-08 | 2004-07-08 | Invitrogen Corporation | Methods and compositions for the production, identification and purification of fusion proteins |
GB2392158B (en) * | 2002-08-21 | 2005-02-16 | Proimmune Ltd | Chimeric MHC protein and oligomer thereof |
GB2408507B (en) * | 2003-10-06 | 2005-12-14 | Proimmune Ltd | Chimeric MHC protein and oligomer thereof for specific targeting |
GB2409456B (en) * | 2003-10-30 | 2006-01-04 | Proimmune Ltd | Oligomeric receptor ligand pair member complexes |
GB2424645B (en) * | 2005-04-01 | 2007-06-06 | Proimmune Ltd | Method of producing a set of MHC molecules |
-
2006
- 2006-07-25 GB GB0614735A patent/GB2442048B/en active Active
-
2007
- 2007-01-31 US US11/699,988 patent/US20080038282A1/en not_active Abandoned
- 2007-02-01 DE DE602007012176T patent/DE602007012176D1/de active Active
- 2007-02-01 AT AT07101561T patent/ATE496943T1/de not_active IP Right Cessation
- 2007-02-01 DK DK07101561.4T patent/DK1882700T3/da active
- 2007-02-01 EP EP07101561A patent/EP1882700B1/de active Active
-
2014
- 2014-07-24 US US14/340,535 patent/US20150031566A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20080038282A1 (en) | 2008-02-14 |
GB2442048A (en) | 2008-03-26 |
EP1882700B1 (de) | 2011-01-26 |
DE602007012176D1 (de) | 2011-03-10 |
DK1882700T3 (da) | 2011-05-16 |
EP1882700A1 (de) | 2008-01-30 |
GB2442048B (en) | 2009-09-30 |
US20150031566A1 (en) | 2015-01-29 |
GB0614735D0 (en) | 2006-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE496943T1 (de) | Biotinylierte mhc-komplexe und ihre verwendungen | |
CY1121327T1 (el) | Τροποποιημενα αντισωματα anti-il-23p19 | |
CY2016004I1 (el) | ΜΟΡΙΑ ΠΡΟΣΔΕΣΗΣ ΑΝΤΙΓΟΝΟΥ ΜΕ ΑΥΞΗΜΕΝΗ ΣΥΓΓΕΝΕΙΑ ΠΡΟΣΔΕΣΗΣ ΣΤΟΝ ΥΠΟΔΟΧΕΑ Fc ΚΑΙ ΛΕΙΤΟΥΡΓΙΑ ΤΕΛΕΣΤΗ | |
CY1116261T1 (el) | Αντισωματα και ανοσοσυζευγματα και χρησεις αυτων | |
DE602006015793D1 (de) | Proteolipidmembran und lipidmembranen-biosensor | |
DE602006021441D1 (de) | Schlauch zur beförderung von kryogenen fluiden | |
CY1113188T1 (el) | Τροποποιημενα fgf-21 πολυπεπτιδια και οι χρησεις τους | |
NL2000141A1 (nl) | Oppervlaktelichtbron welke gebruik maakt van een LED en rugverlichtingseenheid welke de oppervlaktelichtbron heeft. | |
DE602007009373D1 (de) | Kombination aus einem anti-edb-fibronectin-domänen-antikörper/il2-fusionsprotein und einem weiteren kleinen molekül | |
DE602007005044D1 (de) | Fahrzeugbeleuchtungsvorrichtung | |
DK2019772T3 (da) | Køretøj med låsbart tippesystem | |
MA28989B1 (fr) | MOLECULES Fc MODIFIEES | |
NO20083397L (no) | Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse | |
WO2008055257A3 (en) | Cartridge for conducting diagnostic assays | |
NO20091064L (no) | Antistoffer mot IL-17A | |
DE602006000779D1 (de) | Planetenreibradantriebsvorrichtung und Lenkeinrichtung mit einer solchen | |
DE602006012131D1 (de) | Pedalsystem und Fahrzeug mit Pedalsystem | |
DK1864129T3 (da) | Doxurubicin-immunassay | |
AU302970S (en) | Bracket comprising of two parts | |
DE602006019404D1 (de) | Docetaxel-immuntest | |
DE502006006095D1 (de) | Fahrzeugkran mit Ballastierung | |
NO20091181L (no) | Anti-C5AR-antistoffer med forbedrede egenskaper | |
ATE537183T1 (de) | Hiv-fusionshemmerpeptide mit verbesserten biologischen eigenschaften | |
DE602007004999D1 (de) | 1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulen-derivate als orexinrezeptor-antagonisten | |
DE602005010879D1 (de) | Elektronisches Routenanzeigesystem und Navigationssystem, das dieses umfasst |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |